A Detailed Analysis of the Fungal Keratitis Treatment Market Based on an Increasing Global Incidence of Fungal Eye Infections
Report ID: PMRREP33958
Number of Pages: 198
Format: PPT*, PDF, EXCEL
Industry: Healthcare
Published Date: January-2024
1. Executive Summary
1.1. Global Fungal Keratitis Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Type Lifecycle Analysis
2.4. Fungal Keratitis Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Fungal Keratitis Treatment Market Outlook: Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
3.3.3.1. Aspergillus keratitis
3.3.3.2. Fusarium keratitis
3.3.3.3. Candida keratitis
3.3.3.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
3.4. Market Attractiveness Analysis: Type
3.5. Global Fungal Keratitis Treatment Market Outlook: Drug Formulation
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Drug Formulation, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
3.5.3.1. Tablets
3.5.3.2. Eye Drops
3.5.3.3. Ophthalmic Ointments
3.5.3.4. Subconjunctival Injections
3.6. Market Attractiveness Analysis: Drug Formulation
3.7. Global Fungal Keratitis Treatment Market Outlook: Route of Administration
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Route of Administration, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
3.7.3.1. Topical eye drops or ointments
3.7.3.2. Oral antifungal medications
3.7.3.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
3.8. Market Attractiveness Analysis: Route of Administration
3.9. Global Fungal Keratitis Treatment Market Outlook: End User
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
3.9.3.1. Hospitals and clinics
3.9.3.2. Ophthalmic centers and eye hospitals
3.9.3.3. Ambulatory surgical centers (ASCs)
3.9.3.4. Homecare settings
3.10. Market Attractiveness Analysis: End User
4. Global Fungal Keratitis Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Type
5.3.3. By Drug Formulation
5.3.4. By Route of Administration
5.3.5. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
5.5.1. Aspergillus keratitis
5.5.2. Fusarium keratitis
5.5.3. Candida keratitis
5.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
5.6.1. Tablets
5.6.2. Eye Drops
5.6.3. Ophthalmic Ointments
5.6.4. Subconjunctival Injections
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
5.7.1. Topical eye drops or ointments
5.7.2. Oral antifungal medications
5.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
5.8.1. Hospitals and clinics
5.8.2. Ophthalmic centers and eye hospitals
5.8.3. Ambulatory surgical centers (ASCs)
5.8.4. Homecare settings
5.9. Market Attractiveness Analysis
6. Europe Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Type
6.3.3. By Drug Formulation
6.3.4. By Route of Administration
6.3.5. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
6.5.1. Aspergillus keratitis
6.5.2. Fusarium keratitis
6.5.3. Candida keratitis
6.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
6.6.1. Tablets
6.6.2. Eye Drops
6.6.3. Ophthalmic Ointments
6.6.4. Subconjunctival Injections
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
6.7.1. Topical eye drops or ointments
6.7.2. Oral antifungal medications
6.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
6.8.1. Hospitals and clinics
6.8.2. Ophthalmic centers and eye hospitals
6.8.3. Ambulatory surgical centers (ASCs)
6.8.4. Homecare settings
6.9. Market Attractiveness Analysis
7. East Asia Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Type
7.3.3. By Drug Formulation
7.3.4. By Route of Administration
7.3.5. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
7.5.1. Aspergillus keratitis
7.5.2. Fusarium keratitis
7.5.3. Candida keratitis
7.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
7.6.1. Tablets
7.6.2. Eye Drops
7.6.3. Ophthalmic Ointments
7.6.4. Subconjunctival Injections
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
7.7.1. Topical eye drops or ointments
7.7.2. Oral antifungal medications
7.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
7.8.1. Hospitals and clinics
7.8.2. Ophthalmic centers and eye hospitals
7.8.3. Ambulatory surgical centers (ASCs)
7.8.4. Homecare settings
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Type
8.3.3. By Drug Formulation
8.3.4. By Route of Administration
8.3.5. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
8.5.1. Aspergillus keratitis
8.5.2. Fusarium keratitis
8.5.3. Candida keratitis
8.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
8.6.1. Tablets
8.6.2. Eye Drops
8.6.3. Ophthalmic Ointments
8.6.4. Subconjunctival Injections
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
8.7.1. Topical eye drops or ointments
8.7.2. Oral antifungal medications
8.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
8.8.1. Hospitals and clinics
8.8.2. Ophthalmic centers and eye hospitals
8.8.3. Ambulatory surgical centers (ASCs)
8.8.4. Homecare settings
8.9. Market Attractiveness Analysis
9. Latin America Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Type
9.3.3. By Drug Formulation
9.3.4. By Route of Administration
9.3.5. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
9.5.1. Aspergillus keratitis
9.5.2. Fusarium keratitis
9.5.3. Candida keratitis
9.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
9.6.1. Tablets
9.6.2. Eye Drops
9.6.3. Ophthalmic Ointments
9.6.4. Subconjunctival Injections
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
9.7.1. Topical eye drops or ointments
9.7.2. Oral antifungal medications
9.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
9.8.1. Hospitals and clinics
9.8.2. Ophthalmic centers and eye hospitals
9.8.3. Ambulatory surgical centers (ASCs)
9.8.4. Homecare settings
9.9. Market Attractiveness Analysis
10. Middle East & Africa Fungal Keratitis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Type
10.3.3. By Drug Formulation
10.3.4. By Route of Administration
10.3.5. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Type, 2023 - 2030
10.5.1. Aspergillus keratitis
10.5.2. Fusarium keratitis
10.5.3. Candida keratitis
10.5.4. Other fungal keratitis (e.g., Cryptococcus neoformans, Mucorales)
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Drug Formulation, 2023 - 2030
10.6.1. Tablets
10.6.2. Eye Drops
10.6.3. Ophthalmic Ointments
10.6.4. Subconjunctival Injections
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Route of Administration, 2023 - 2030
10.7.1. Topical eye drops or ointments
10.7.2. Oral antifungal medications
10.7.3. Intravenous (IV) antifungal medications (for severe or invasive fungal keratitis)
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
10.8.1. Hospitals and clinics
10.8.2. Ophthalmic centers and eye hospitals
10.8.3. Ambulatory surgical centers (ASCs)
10.8.4. Homecare settings
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Dashboard
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Novartis AG
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Eyevance Pharmaceuticals, LLC (Santen Holdings United States Inc.)
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. AbbVie Inc.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Pfizer Inc.
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Merck and Co. (Merck KGaA)
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Bausch Health Companies Inc.
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Cipla Inc.
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Wellona Pharma
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. LEXICARE PHARMA PVT. LTD
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Salvus Pharma
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
